FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310706083> ?p ?o ?g. }

• W4310706083 abstract "Diabetic foot ulcers (DFU) are one of the leading long-term complications experienced by patients with diabetes. Dipeptidyl Peptidase 4 inhibitors (DPP4is) are a class of antihyperglycemic medications prescribed to patients with diabetes to manage glycaemic control. DPP4is may also have a beneficial effect on DFU healing. This study aimed to determine vildagliptin's effect on inflammatory markers and wound healing.Prospective, randomized, double-blind, placebo-controlled, single-center study.Equal number of participants were randomized into the treatment and placebo groups. The treatment was for 12 weeks, during which the participants had regular visits to the podiatrist, who monitored their DFU sizes using 3D camera, and blood samples were taken at baseline, six weeks, and 12 weeks during the study for measurement of inflammatory markers. In addition, demographic characteristics, co-morbidities, DFU risk factors, and DFU wound parameters were recorded.50 participants were recruited for the study, with 25 assigned to placebo and 25 to treatment group. Vildagliptin treatment resulted in a statistically significant reduction of HBA1c (p < 0.02) and hematocrit (p < 0.04), total cholesterol (p < 0.02), LDL cholesterol (p < 0.04), and total/HDL cholesterol ratio (P < 0.03) compared to the placebo group. Also, vildagliptin had a protective effect on DFU wound healing, evidenced by the odds ratio (OR) favoring the intervention of 11.2 (95% CI 1.1-113.5; p < 0.04) and the average treatment effect on the treated (ATET) for vildagliptin treatment group showed increased healing by 35% (95%CI; 10-60, p = 0.01) compared to placebo with the model adjusted for microvascular complications, smoking, amputation, dyslipidemia, peripheral vascular disease (PVD) and duration of diabetes.Vildagliptin treatment was effective in healing DFU in addition to controlling the diabetes. Our findings support the use of DPP4is as a preferred option for treating ulcers in patients with diabetes. Further studies on a larger population are warranted to confirm our findings and understand how DPP4is could affect inflammation and DFU healing." @default.
• W4310706083 created "2022-12-16" @default.
• W4310706083 creator A5008329729 @default.
• W4310706083 creator A5010187364 @default.
• W4310706083 creator A5011863069 @default.
• W4310706083 creator A5015810755 @default.
• W4310706083 creator A5021913794 @default.
• W4310706083 creator A5051426823 @default.
• W4310706083 creator A5051640404 @default.
• W4310706083 creator A5079038166 @default.
• W4310706083 creator A5085674652 @default.
• W4310706083 date "2022-12-02" @default.
• W4310706083 modified "2023-10-10" @default.
• W4310706083 title "Effects of vildagliptin on wound healing and markers of inflammation in patients with type 2 diabetic foot ulcer: a prospective, randomized, double-blind, placebo-controlled, single-center study" @default.
• W4310706083 cites W1518038365 @default.
• W4310706083 cites W2016632734 @default.
• W4310706083 cites W2020752464 @default.
• W4310706083 cites W2020847946 @default.
• W4310706083 cites W2026736490 @default.
• W4310706083 cites W2029366332 @default.
• W4310706083 cites W2049269905 @default.
• W4310706083 cites W2059903872 @default.
• W4310706083 cites W2064130493 @default.
• W4310706083 cites W2080072660 @default.
• W4310706083 cites W2105310414 @default.
• W4310706083 cites W2111069331 @default.
• W4310706083 cites W2145025407 @default.
• W4310706083 cites W2150859826 @default.
• W4310706083 cites W2152102353 @default.
• W4310706083 cites W2158861275 @default.
• W4310706083 cites W2161971786 @default.
• W4310706083 cites W2432241657 @default.
• W4310706083 cites W2619552711 @default.
• W4310706083 cites W2779440437 @default.
• W4310706083 cites W2940473222 @default.
• W4310706083 cites W2990047823 @default.
• W4310706083 cites W3013660363 @default.
• W4310706083 cites W3013892292 @default.
• W4310706083 cites W3176227937 @default.
• W4310706083 cites W287957845 @default.
• W4310706083 doi "https://doi.org/10.1186/s13098-022-00938-2" @default.
• W4310706083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36456992" @default.
• W4310706083 hasPublicationYear "2022" @default.
• W4310706083 type Work @default.
• W4310706083 citedByCount "1" @default.
• W4310706083 countsByYear W43107060832023 @default.
• W4310706083 crossrefType "journal-article" @default.
• W4310706083 hasAuthorship W4310706083A5008329729 @default.
• W4310706083 hasAuthorship W4310706083A5010187364 @default.
• W4310706083 hasAuthorship W4310706083A5011863069 @default.
• W4310706083 hasAuthorship W4310706083A5015810755 @default.
• W4310706083 hasAuthorship W4310706083A5021913794 @default.
• W4310706083 hasAuthorship W4310706083A5051426823 @default.
• W4310706083 hasAuthorship W4310706083A5051640404 @default.
• W4310706083 hasAuthorship W4310706083A5079038166 @default.
• W4310706083 hasAuthorship W4310706083A5085674652 @default.
• W4310706083 hasBestOaLocation W43107060831 @default.
• W4310706083 hasConcept C126322002 @default.
• W4310706083 hasConcept C134018914 @default.
• W4310706083 hasConcept C141071460 @default.
• W4310706083 hasConcept C142724271 @default.
• W4310706083 hasConcept C168563851 @default.
• W4310706083 hasConcept C188816634 @default.
• W4310706083 hasConcept C204787440 @default.
• W4310706083 hasConcept C27081682 @default.
• W4310706083 hasConcept C2776453732 @default.
• W4310706083 hasConcept C2777180221 @default.
• W4310706083 hasConcept C2777858829 @default.
• W4310706083 hasConcept C2778144972 @default.
• W4310706083 hasConcept C2780269544 @default.
• W4310706083 hasConcept C555293320 @default.
• W4310706083 hasConcept C71924100 @default.
• W4310706083 hasConcept C90924648 @default.
• W4310706083 hasConceptScore W4310706083C126322002 @default.
• W4310706083 hasConceptScore W4310706083C134018914 @default.
• W4310706083 hasConceptScore W4310706083C141071460 @default.
• W4310706083 hasConceptScore W4310706083C142724271 @default.
• W4310706083 hasConceptScore W4310706083C168563851 @default.
• W4310706083 hasConceptScore W4310706083C188816634 @default.
• W4310706083 hasConceptScore W4310706083C204787440 @default.
• W4310706083 hasConceptScore W4310706083C27081682 @default.
• W4310706083 hasConceptScore W4310706083C2776453732 @default.
• W4310706083 hasConceptScore W4310706083C2777180221 @default.
• W4310706083 hasConceptScore W4310706083C2777858829 @default.
• W4310706083 hasConceptScore W4310706083C2778144972 @default.
• W4310706083 hasConceptScore W4310706083C2780269544 @default.
• W4310706083 hasConceptScore W4310706083C555293320 @default.
• W4310706083 hasConceptScore W4310706083C71924100 @default.
• W4310706083 hasConceptScore W4310706083C90924648 @default.
• W4310706083 hasFunder F4320334531 @default.
• W4310706083 hasIssue "1" @default.
• W4310706083 hasLocation W43107060831 @default.
• W4310706083 hasLocation W43107060832 @default.
• W4310706083 hasLocation W43107060833 @default.
• W4310706083 hasLocation W43107060834 @default.
• W4310706083 hasLocation W43107060835 @default.
• W4310706083 hasOpenAccess W4310706083 @default.
• W4310706083 hasPrimaryLocation W43107060831 @default.
• W4310706083 hasRelatedWork W2077321957 @default.
• W4310706083 hasRelatedWork W2183209921 @default.

• next